The global Europe Platelet rich Plasma Market Growth Accelerated by Increasing Adoption in Cosmetic surgeries
Platelet-rich plasma (PRP) is a concentrate of platelets derived from the blood plasma with a number of growth factors and proteins. PRP therapy is being increasingly used in cosmetic surgeries such as hair restoration, fat grafting, and wound healing. It helps in boosting skin rejuvenation process and promoting hair growth. Due to the anti-inflammatory and healing properties of PRP, it is in high demand among cosmetic surgeons.
The
global Europe Platelet rich Plasma Market is estimated to be valued at US$
127.19 Mn in 2024 and is expected to exhibit a CAGR of 5.3% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of PRP in cosmetic surgeries is one of the major
factor driving the growth of Europe platelet rich plasma market. PRP therapy is
vastly used in hair restoration procedures as it helps in regrowing hairs on
bald patches. Additionally, PRP finds application in anti-aging treatments as
it helps reduce wrinkles, stretch marks and rejuvenate the skin. Cosmetic
surgeons prefer PRP over other dermal fillers as it uses patients' own blood
platelets and growth factors to stimulate tissue regeneration resulting in
long-lasting effects. However, high capital investment in processing
platelet-rich plasma and dearth of skilled professionals remain key challenges
for market participants over the forecast period.
Segment Analysis
The Europe
platelet rich plasma market size is segmented on the basis of type,
application, end user and geography. By type, the platelet rich plasma market
can be segmented into pure platelet-rich plasma and leukocyte-rich
platelet-rich plasma. The pure platelet-rich plasma segment dominates the
market as it is widely used in orthopedic & sports medicine applications
for tendinopathy and ligament sprains. By application, the market covers
multiple segments such as orthopedic surgery, cosmetic surgery, general surgery
and others. Among these, the orthopedic surgery segment has the highest market
share due to increasing usage of platelet rich plasma for tendinopathy, muscle
strain, osteoarthritis and ligament sprains. Geographically, countries like
Germany, France and UK hold a significant share in the Europe platelet rich
plasma market due to established healthcare infrastructure and rising adoption
of platelet rich plasma therapy.
Key Takeaways
The
global Europe Platelet rich Plasma Market is estimated to be valued at US$
127.19 Mn in 2024 and is expected to exhibit a CAGR of 5.3% over the forecast
period 2024 to 2031.
Regional analysis
The Europe platelet rich plasma market is expected to be dominated by
Germany, France and the UK. This is mainly attributed to factors such as
established healthcare infrastructure, rising healthcare spending, growing
awareness about platelet rich plasma therapy and presence of key industry
players in these countries. Germany is anticipated to witness the highest
growth during the forecast period owing to rapidly expanding medical technology
industry, high disposable incomes and growing medical tourism.
Key players
Key players operating in the Europe Platelet rich Plasma Market are
Husqvarna Group, Stiga, Stihl, Robert Bosch, Oregon Tools, Active, Al-Ko Kober,
Einhell Germany, Cobra, Emak Group. Husqvarna Group and Stihl collectively
account for over 50% market share due to their strong brand recognition and
wide distribution network across the region.
Get
more insights on this topic: https://www.newsstatix.com/europe-platelet-rich-plasma-market-share-and-opportunity-analysis/
Comments
Post a Comment